The 2023 "Yujian Cup" Medical Examination Artificial Intelligence Developer Competition, sponsored by Guangzhou Jinyu Medical Laboratory Group (hereinafter referred to as Jinyu Medicine) and Guangdong Artificial Intelligence Industry Association, has recently concluded. At the award ceremony, the artificial intelligence open innovation platform for clinical testing and pathological diagnosis, built by Jinyu Medical, was officially launched. This is the first open innovation platform for artificial intelligence in the Chinese medical examination industry, which can meet the one-stop AI research and development needs of developers from data management to application deployment. It has the characteristics of full stack, full process, and full scenario. It is reported that the open innovation platform for clinical laboratory and pathological diagnosis artificial intelligence provides services to startups, medical research institutions, individual developers, industry experts, and other users. Developers can use publicly available datasets for model training on the platform, as well as gain affordable computing power to support data processing and the development of various models. In addition, the platform's one-stop model training service provides users with mainstream algorithm and development frameworks, rich computing resources, and compliant and available training data, minimizing user research and development costs. At present, the platform has launched multiple disease diagnosis datasets processed by medical examination experts, achieving secure sharing of sample resources, high-quality medical examination data, and case labeling data. Through stable, reliable, sustainable and innovative cloud services, the platform can protect user data security and complete the training of common models while meeting the needs of multiple developers and keeping data within the domain. Liang Xiaodan, Vice President of Jinyu Medical, stated that he hopes to drive the integration of data, technology, and industry chain resources through this platform, and promote the formation of an artificial intelligence industry cluster in the field of medical examination. It is reported that the platform can also support the development of small and medium-sized medical AI enterprises in the industry by gathering industrial resources, promoting industry exchanges, accelerating research and development processes, and assisting in application implementation, in order to better build a medical AI ecosystem that integrates biotechnology and the new generation of information technology, and promote innovation and industrial development of the new generation of artificial intelligence technology in Guangdong Province and even the whole country. (New News Agency)